NAMS
NewAmsterdam Pharma Company N.V.
23.20$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -0.41 | -1.66 | 0.56 | -1.72 | -1.68 | -1.29 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.07 | 0.22 | 0.30 | 0.36 | 0.52 | |
| 0.02 | -0.02 | – | – | – | – | |
| -0.04 | 0.25 | 0.55 | 0.07 | -0.35 | -0.07 | |
| 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | |
| 0.00 | 0.00 | -0.01 | 0.00 | -0.67 | -1.53 | |
| 0.64 | 0.00 | 0.04 | 0.00 | 0.00 | – | |
| 0.78 | 4.77 | 20.66 | 0.11 | 6.99 | 0.26 | |
| 0.37 | 2.84 | 21.49 | -1.55 | 4.57 | -2.45 | |
| -0.41 | -1.66 | 0.55 | -1.72 | -1.69 | -1.29 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.